Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Cash from Operations (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Cash from Operations for 6 consecutive years, with 3195000.0 as the latest value for Q4 2018.

  • Quarterly Cash from Operations fell 34.87% to 3195000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was 10627000.0 through Dec 2018, down 15.61% year-over-year, with the annual reading at 25763000.0 for FY2025, 31.39% up from the prior year.
  • Cash from Operations hit 3195000.0 in Q4 2018 for Armata Pharmaceuticals, down from 2020000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 593000.0 in Q3 2017 to a low of 3691000.0 in Q1 2014.
  • Historically, Cash from Operations has averaged 2638900.0 across 5 years, with a median of 2777000.0 in 2015.
  • Biggest five-year swings in Cash from Operations: skyrocketed 81.06% in 2017 and later crashed 240.64% in 2018.
  • Year by year, Cash from Operations stood at 3200000.0 in 2014, then increased by 27.59% to 2317000.0 in 2015, then soared by 35.35% to 1498000.0 in 2016, then tumbled by 58.14% to 2369000.0 in 2017, then plummeted by 34.87% to 3195000.0 in 2018.
  • Business Quant data shows Cash from Operations for ARMP at 3195000.0 in Q4 2018, 2020000.0 in Q3 2018, and 1876000.0 in Q2 2018.